420 related articles for article (PubMed ID: 25996677)
1. Hypoxia pretreatment of bone marrow mesenchymal stem cells facilitates angiogenesis by improving the function of endothelial cells in diabetic rats with lower ischemia.
Liu J; Hao H; Xia L; Ti D; Huang H; Dong L; Tong C; Hou Q; Zhao Y; Liu H; Fu X; Han W
PLoS One; 2015; 10(5):e0126715. PubMed ID: 25996677
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia regulates the therapeutic potential of mesenchymal stem cells through enhanced autophagy.
Liu J; Hao H; Huang H; Tong C; Ti D; Dong L; Chen D; Zhao Y; Liu H; Han W; Fu X
Int J Low Extrem Wounds; 2015 Mar; 14(1):63-72. PubMed ID: 25759412
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment of mesenchymal stem cells with angiotensin II enhances paracrine effects, angiogenesis, gap junction formation and therapeutic efficacy for myocardial infarction.
Liu C; Fan Y; Zhou L; Zhu HY; Song YC; Hu L; Wang Y; Li QP
Int J Cardiol; 2015 Jun; 188():22-32. PubMed ID: 25880576
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia pretreatment of bone marrow-derived mesenchymal stem cells seeded in a collagen-chitosan sponge scaffold promotes skin wound healing in diabetic rats with hindlimb ischemia.
Tong C; Hao H; Xia L; Liu J; Ti D; Dong L; Hou Q; Song H; Liu H; Zhao Y; Fu X; Han W
Wound Repair Regen; 2016; 24(1):45-56. PubMed ID: 26463737
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia pretreatment improves the therapeutic potential of bone marrow mesenchymal stem cells in hindlimb ischemia via upregulation of NRG-1.
Peng X; Liang B; Wang H; Hou J; Yuan Q
Cell Tissue Res; 2022 Apr; 388(1):105-116. PubMed ID: 35091805
[TBL] [Abstract][Full Text] [Related]
6. Deferoxamine preconditioning potentiates mesenchymal stem cell homing in vitro and in streptozotocin-diabetic rats.
Najafi R; Sharifi AM
Expert Opin Biol Ther; 2013 Jul; 13(7):959-72. PubMed ID: 23536977
[TBL] [Abstract][Full Text] [Related]
7. Uremia induces functional incompetence of bone marrow-derived stromal cells.
Noh H; Yu MR; Kim HJ; Jeon JS; Kwon SH; Jin SY; Lee J; Jang J; Park JO; Ziyadeh F; Han DC; Lee HB
Nephrol Dial Transplant; 2012 Jan; 27(1):218-25. PubMed ID: 21622994
[TBL] [Abstract][Full Text] [Related]
8. Peptide hormone ELABELA promotes rat bone marrow-derived mesenchymal stem cell proliferation and migration by manipulating the cell cycle through the PI3K/AKT pathway under the hypoxia and ischemia microenvironment.
Chen X; Zhou C; Xu D; Liu X; Li S; Hou J; Zhang K; Zeng C; Zheng G; Wu H; Wu H; Wang W; Fu J; Wang T
Stem Cell Res Ther; 2022 Jan; 13(1):32. PubMed ID: 35090551
[TBL] [Abstract][Full Text] [Related]
9. Omentin-1 effects on mesenchymal stem cells: proliferation, apoptosis, and angiogenesis in vitro.
Yin L; Huang D; Liu X; Wang Y; Liu J; Liu F; Yu B
Stem Cell Res Ther; 2017 Oct; 8(1):224. PubMed ID: 29017592
[TBL] [Abstract][Full Text] [Related]
10. The angiogenic related functions of bone marrow mesenchymal stem cells are promoted by CBDL rat serum via the Akt/Nrf2 pathway.
Shen CC; Chen B; Gu JT; Ning JL; Chen L; Zeng J; Yi B; Lu KZ
Exp Cell Res; 2016 May; 344(1):86-94. PubMed ID: 27105936
[TBL] [Abstract][Full Text] [Related]
11. IL-8 enhances the angiogenic potential of human bone marrow mesenchymal stem cells by increasing vascular endothelial growth factor.
Hou Y; Ryu CH; Jun JA; Kim SM; Jeong CH; Jeun SS
Cell Biol Int; 2014 Sep; 38(9):1050-9. PubMed ID: 24797366
[TBL] [Abstract][Full Text] [Related]
12. Bone Marrow Stromal Cells Combined With Sodium Ferulate and
Zhang Q; Chen ZW; Zhao YH; Liu BW; Liu NW; Ke CC; Tan HM
Cell Transplant; 2017 Feb; 26(2):229-242. PubMed ID: 27772541
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow mesenchymal stromal cells ameliorate angiogenesis and renal damage via promoting PI3k-Akt signaling pathway activation in vivo.
Jia X; Pan J; Li X; Li N; Han Y; Feng X; Cui J
Cytotherapy; 2016 Jul; 18(7):838-45. PubMed ID: 27210720
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow-derived mesenchymal stem cells induced by inflammatory cytokines produce angiogenetic factors and promote prostate cancer growth.
Yang KQ; Liu Y; Huang QH; Mo N; Zhang QY; Meng QG; Cheng JW
BMC Cancer; 2017 Dec; 17(1):878. PubMed ID: 29268703
[TBL] [Abstract][Full Text] [Related]
15. Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis.
Hung SC; Pochampally RR; Chen SC; Hsu SC; Prockop DJ
Stem Cells; 2007 Sep; 25(9):2363-70. PubMed ID: 17540857
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow-derived mesenchymal stem cells enhance autophagy via PI3K/AKT signalling to reduce the severity of ischaemia/reperfusion-induced lung injury.
Li J; Zhou J; Zhang D; Song Y; She J; Bai C
J Cell Mol Med; 2015 Oct; 19(10):2341-51. PubMed ID: 26177266
[TBL] [Abstract][Full Text] [Related]
17. Hypoxic mesenchymal stem cells engraft and ameliorate limb ischaemia in allogeneic recipients.
Huang WH; Chen HL; Huang PH; Yew TL; Lin MW; Lin SJ; Hung SC
Cardiovasc Res; 2014 Feb; 101(2):266-76. PubMed ID: 24220639
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival.
Huang F; Zhu X; Hu XQ; Fang ZF; Tang L; Lu XL; Zhou SH
Int J Mol Med; 2013 Feb; 31(2):484-92. PubMed ID: 23229021
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia preconditioned human adipose derived mesenchymal stem cells enhance angiogenic potential via secretion of increased VEGF and bFGF.
Liu L; Gao J; Yuan Y; Chang Q; Liao Y; Lu F
Cell Biol Int; 2013 Jun; 37(6):551-60. PubMed ID: 23505143
[TBL] [Abstract][Full Text] [Related]
20. Neurotrophic effect of bone marrow mesenchymal stem cells for erectile dysfunction in diabetic rats.
Sun C; Lin H; Yu W; Li X; Chen Y; Qiu X; Wang R; Dai Y
Int J Androl; 2012 Aug; 35(4):601-7. PubMed ID: 22428616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
